HKEX:6990 stock news
This page provides real-time market news, earnings updates, and company announcements related to Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HKEX:6990).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 09:03 HKT
PBOC Maintains Crypto Prohibition, While Illicit Mining Continues to Flourish
Bitget-RWA2025-12-01 06:50:08
China’s expanding gas market raises concerns about future LNG demand
101 finance2026-01-11 00:51:11
Oil prices jump as ‘tankers hit by drones’
101 finance2026-01-13 19:15:27
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
Finviz2026-02-18 12:33:42
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Finviz2026-02-25 13:00:55
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients
Finviz2026-02-26 19:27:04
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Finviz2026-02-25 13:00:55
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients
Finviz2026-02-26 19:27:04
HKEX:6990 stock price change
On the last trading day, HKEX:6990 stock closed at 381.00 HKD, with a price change of -4.75% for the day.
Trade stock perpsHKEX:6990 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more